July 4, 2025
TOPLINE: Remote monitoring and patient-initiated care matched usual care in maintaining low disease activity in patients with axial spondyloarthritis (axSpA) on stable TNF inhibitor therapy. METHODOLOGY: […]
July 3, 2025
TOPLINE: Abatacept outperformed hydroxychloroquine (HCQ) in preventing patients with palindromic rheumatism (PR) from progressing to rheumatoid arthritis (RA). METHODOLOGY: Researchers randomly assigned 70 individuals with PR […]
July 3, 2025
Despite the rising incidence of rheumatoid arthritis (RA), extra-articular manifestations have become rare in the era of modern treat-to-target therapy. However, they still present clinical challenges […]
July 2, 2025
TOPLINE: The whole-body MRI revealed similar inflammation levels in both patients with new arthralgia and those with new inflammatory arthritis after exposure to immune checkpoint inhibitors […]
July 2, 2025
BARCELONA, Spain — Treatment with abatacept delays the onset of rheumatoid arthritis (RA) in patients at high risk of developing the disease, according to data presented […]
July 1, 2025
TOPLINE: Ivarmacitinib, a highly selective Janus kinase 1 (JAK1) inhibitor, tamed ankylosing spondylitis with sustained efficacy through 24 weeks in a phase 2/3 trial. METHODOLOGY: A […]
June 30, 2025
BARCELONA, Spain — Efgartigimod could have a role to play in the treatment of both myositis and Sjögren disease, according to data from two “proof-of-concept” phase […]
June 30, 2025
The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS) in known or suspected Still disease. This is […]
June 30, 2025
TOPLINE: Most patients with early, active axial spondyloarthritis (axSpA) achieved remission in a tight control treatment with golimumab, regardless of gut inflammation, in a small, single-arm […]